The role of the insulin-like growth factor I receptor in transformation and apoptosis

Annals of the New York Academy of Sciences

Volumn 842, Issue , 1998, Pages 76-81

  Resnicoff, Mariana ^a   Baserga, Renato ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION; CONFERENCE PAPER; MITOGENESIS; PHENOTYPE;

EID: 0031959117     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09634.x     Document Type: Conference Paper

References (33)

1. ULLRICH, A., A. GRAY, A.W. TAM, T. YANG-FENG, M. TSUBOKAWA, C. COLLINS, W. HENZEL, T. LE BON, S. KAHURIA, E. CHEN, S. JAKOBS, U. FRANCKE, J. RAMACHANDRAN & Y. FUJITA-YAMAGUCHI. 1986. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5: 2503-2512.
2. MYERS, M.G., X.J. SUN, B. CHEATHAM, B.R. JACHNA, E.M. GLASHEEN, J.M. BACKER & M.F. WHITE 1993. IRS-1 is a common element in insulin and insulin-like growth factor I signaling to the phosphatidylinositol 3′ kinase. Endocrinology 132: 1421-1430.
3. WHITE, M.F. & C.R. KAHN. 1994. The insulin signaling system. J. Biol. Chem. 269: 1-4.
4. CREWS, C.M. & R.L. ERIKSON. 1993. Extracellular signals and reversible protein phosphorylation: What to MEK of it all. Cell 74: 215-217.
5. HILL, C.S. & R. TREISMAN. 1995. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell 80: 199-211.
6. BASERGA, R. 1995. The IGF-I receptor: A key to tumor growth? Cancer Res. 55: 249-252.
7. LIU, J.P., J. BAKER, A.S. PERKINS, E.J. ROBERTSON & A. EFSTRATIADIS. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (igf-1) and type I IGF receptor (igf 1 r). Cell 75: 59-72.
8. BAKER, J., J.P. LIU, E.J. ROBERTSON & A. EFSTRATIADIS. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82.
9. SELL, C., M. RUBINI, R. RUBIN, J.P. LIU, A. EFSTRATIADIS & R. BASERGA. 1993. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type I IGF receptor. Proc. Natl. Acad. Sci. USA 90: 11217-11221.
10. SELL, C., G. DUMENIL, C. DEVEAUD, M. MIURA, D. COPPOLA, T. DE ANGELIS, R. RUBIN, A. EFSTRATIADIS & R. BASERGA. 1994. Effect of a null mutation of the type I IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14: 3604-3612.
11. VALENTINIS, B., P.L. PORCU, K. QUINN & R. BASERGA. 1994. The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen. Oncogene 9: 825-831.
12. COPPOLA, D., A. FERBER, M. MIURA, C. SELL, C. D'AMBROSIO, R. RUBIN & BASERGA. 1994. A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol. Cell. Biol. 14: 4588-4595.
13. DE ANGELIS, T., A. FERBER & R. BASERGA. 1995. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J. Cell. Physiol. 164: 214-221.
14. RESNICOFF, M., D. AMBROSE, D. COPPOLA & R. RUBIN. 1993. Insulin-like growth factor I and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab. Invest. 69: 756-760.
15. RESNICOFF, M., C. SELL, M. RUBINI, D. COPPOLA, D. AMBROSE, R. BASERGA & R. RUBIN. 1994. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor I (IGF-I) receptor are non-tumorigenic and induce regression of wild-type tumors. Cancer Res. 54: 2218-2222.
16. RESNICOFF, M., D. COPPOLA, C. SELL, R. RUBIN, S. FERRONE & R. BASERGA. 1994. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54: 4848-4850.
17. AMBROSE, D., M. RESNICOFF, D. COPPOLA, C. SELL, M. MIURA, S. JAMESON, R. BASERGA & R. RUBIN. 1994. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor 1 and its receptor. J. Cell. Physiol. 159: 92-100.
18. SHAPIRO, D.N., B.G. JONES, L.H. SHAPIRO, P. DIAS & P.J. HOUGHTON. 1994. Antisense-mediated reduction in insulin-like growth factor I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest. 94: 1235-1242.
19. TROJAN, J., B.K. BLOSSEV, T.R. JOHNSON, S.D. RUDIN, M. TYKOCINSKI, J. ILAN & J. ILAN. 1992. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 89: 4874-4878.
20. TROJAN, J., T.R. JOHNSON, S.D. RUDIN, J. ILAN, M.L. TYKOCINSKI & J. ILAN. 1993. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor 1 RNA. Science 259: 94-97.
21. CHRISTOFORI, G., P. NAIK & D. HANAHAN. 1994. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369: 414-418.
22. ARTEAGA, C.L. & C.K. OSBORNE. 1989 Growth inhibition of human breast cancer cells in vitro with an antibody against the type 1 somatomedin receptor. Cancer Res. 49: 6237-6241.
23. KALEBIC, T., M. TSOKOS & L.J. HELMAN. 1994. In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34 cdc2. Cancer Res. 54: 5531-5534.
24. LI, S., A. FERBER, M. MIURA & R. BASERGA. 1994. Mitogenicity and transforming activity of the insulin-like growth factor I receptor with mutations in the tyrosine kinase domain. J. Biol. Chem. 269: 32558-32564.
25. LI, S., M. RESNICOFF & R. BASERGA. 1996, Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271: 12254-12260.
26. PRAGER, D., H.L. LI, S. ASA & S. MELMED. 1994. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad. Sci. USA 91: 2181-2185.
27. BURGAUD, J-L., M. RESNICOFF & R. BASERGA. 1995. Mutant IGF-1 receptors as dominant negatives for growth and transformation. Biochem. Biophys. Res. Commun. 214: 475-481.
28. D'AMBROSIO, C., A. FERBER, M. RESNICOFF & R. BASERGA. 1996. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res. 56: 4013-4020.
29. ABRAHAM, D., A.M. LANGE, W. YUTANAVIBOONCHAI, M. TRPIS, J.W. DICKERSON, B. SWENSON & M.L. EBERHARD. 1993. Survival and development of larval Onchocerca volvulus in primate and rodent hosts. J. Parasit. 79: 571-582.
30. RESNICOFF, M., D. ABRAHAM, W. YUTANAWIBOONCHAI, H.L. ROTMAN, J. KAJSTURA, R. RUBIN, P. ZOLTIC & R. BASERGA. 1995. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55: 2463-2469.
31. RESNICOFF, M., J.-L. BURGAUD, H. ROTMAN, D. ABRAHAM & R. BASERGA. 1995. Correlation between apoptosis, tumoriaenesis and levels of insulin-like growth factor I receptors. Cancer Res. 55: 3739-3741.
32. RESNICOFF, M., W. LI, S. BASAK, D. HERLYN, R. BASERGA & R. RUBIN. 1996. Mechanisms of rat C6 glioblastoma tumor growth inhibition by expression of insulin-like growth factor I receptor antisense mRNA. Cancer Immunol. Immunother. 42: 64-68.
33. RESNICOFF, M., J. TJUVAJEV, H.L. ROTMAN, D. ABRAHAM, M. CURTIS, R. AIKEN & R. BASERGA. 1996. Regression of C6 rat brain tumors by cells expressing an antisense insulinlike growth factor I receptor RNA. J. Exp. Then Oncol. 1: 385-389.